Form 8-K Praxis Precision Medicin For: Jan 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities climb as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Brazil’s Lula wins historic fourth term, Flavio Bolsonaro refuses to concede
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- Borr Drilling rig sinks off Gabon, one person dead and four missing
- Oil inches higher, stays near six-month highs on Saudi attacks
- Britain will not join Canada-led defence bank initiative
Praxis Precision Medicines (PRAX) Teminates Open Market Sale Agreement
January 11, 2024 6:08 AM ESTAs previously disclosed, on December 7, 2023, Praxis Precision Medicines (NASDAQ: PRAX) entered into an Open Market Sale Agreement SM (the Sales Agreement) with Jefferies LLC (Jefferies), pursuant to which the Company may offer and sell shares of its common stock having an aggregate offering price... More



